IPP Bureau
Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells
By IPP Bureau - April 08, 2022
Essent continues to broaden its highly characterized, low passage primary cell catalog
Pancreatic cancer lab-grown human organoids may predict effective chemotherapy treatment
By IPP Bureau - April 08, 2022
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
By IPP Bureau - April 08, 2022
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
IAVI and Moderna partner to tackle broad global health priorities
By IPP Bureau - April 08, 2022
Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis
CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India
By IPP Bureau - April 08, 2022
Veeda Clinical Research will submit data in an application for Emergency Use Authorisation
Ineos to build acetonitrile plant in Germany
By IPP Bureau - April 08, 2022
The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact
Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test
By IPP Bureau - April 08, 2022
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
Precaution dose for over 18 from April 10 at private vaccination centres
By IPP Bureau - April 08, 2022
About 96% of all 15+ population in the country have received at least one Covid-19 vaccine dose while about 83% of 15+ population has received both the doses
Study reveals over 80 % newly diagnosed diabetic patients have at least one cholesterol abnormality
By IPP Bureau - April 08, 2022
The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted
Sky announces the availability of its geko device on the Indian govt e-marketplace
By IPP Bureau - April 07, 2022
With this move, government hospitals across India can now access the geko device to prevent life-threatening blood clots, and address complications related to swelling following orthopaedic surgery and the healing of chronic wounds (leg ulcers)
BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022
By IPP Bureau - April 07, 2022
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Covestro and PharmaJet work to take the sting out of vaccinations
By IPP Bureau - April 07, 2022
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
MakGroup Healthcare becomes sole distributor of PixCell Medical's HemoScreen in the UAE
By IPP Bureau - April 07, 2022
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
Lupin completes acquisition of brands from Anglo-French
By IPP Bureau - April 07, 2022
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
JB Chemicals and Pharmaceuticals partners with Akshay Chaitanya to provide free lunch in hospitals
By IPP Bureau - April 07, 2022
Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai
